STAAR Surgical Ends Merger with Alcon Due to Shareholder Vote Failure
STAAR Surgical has terminated its merger with Alcon after failing to gain shareholder approval, leading to a 12% drop in share value. Broadwood Partners, STAAR's largest shareholder, opposed the deal, citing undervaluation.
Insights:
STAAR Surgical Company announced on January 6, 2026, that it has terminated its merger agreement with Alcon Inc. following an unsuccessful attempt to secure sufficient shareholder votes for the $1.6 billion deal. The announcement resulted in a sharp 12% decline in STAAR's share price, highlighting the market's reaction to the failed acquisition.
